Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

CH:2CV Stock Latest News

Company AnnouncementsConvatec Non-Executive Director Jens Viebke Increases Stake with Share Purchase2w ago

Company AnnouncementsConvatec Advances $200m Share Buyback, Updates Voting Rights2w ago
Company AnnouncementsConvatec Adds to Treasury Stock with Latest Tranche in $200m Buyback3w ago
Company AnnouncementsConvatec Updates Market on Total Voting Rights and Share Buyback Activity1M ago
Company AnnouncementsConvatec Increases Treasury Stock with Latest Tranche of $200m Buyback1M ago

Convatec Adds to $200m Buyback, Updates Voting Rights

Company AnnouncementsConvatec Adds to $200m Buyback, Updates Voting Rights1M ago

Company AnnouncementsConvatec Advances $200m Share Buyback, Tightens Free Float1M ago

Company AnnouncementsConvatec Advances $200m Buyback, Updates Share Capital and Voting Rights1M ago

Company AnnouncementsConvatec Updates Total Voting Rights Amid Ongoing Share Buyback2M ago
Company AnnouncementsConvatec Advances $200m Buyback, Lifts Treasury Share Holdings2M ago
Company AnnouncementsConvatec strengthens board with medtech veteran Jens Viebke2M ago
Company AnnouncementsConvatec Updates Market on Progress of $200m Share Buyback Programme2M ago

Convatec’s $200m Buyback Pushes Treasury Shares Above FCA Threshold

Company AnnouncementsConvatec’s $200m Buyback Pushes Treasury Shares Above FCA Threshold2M ago

Company AnnouncementsConvatec Continues $200m Buyback, Tightens Share Base and Voting Rights2M ago

Company AnnouncementsConvatec Advances $200m Buyback with New Treasury Share Purchases2M ago

Company AnnouncementsConvaTec Earnings Call Highlights Growth Amid Headwinds2M ago
Company AnnouncementsConvatec Director Tobias Hestler Buys 50,000 Shares in FTSE 100 Medtech Group2M ago
Company AnnouncementsConvatec Director Tobias Hestler Joins Hikma Pharmaceuticals Board2M ago
RatingsRichard Felton Initiates Buy on ConvaTec, Citing Strong Core Franchises, Margin Upside and Attractive Valuation2M ago

Stifel’s Christian Glennie Reiterates Buy on ConvaTec After Solid H1 2026, Tightened Guidance and New $200m Buyback

RatingsStifel’s Christian Glennie Reiterates Buy on ConvaTec After Solid H1 2026, Tightened Guidance and New $200m Buyback2M ago

Company AnnouncementsConvaTec Corrects Dividend Figure as It Reaffirms 2026 Guidance and Launches $200m Buyback2M ago

Company AnnouncementsConvatec Launches $200 Million Share Buyback Programme2M ago